MYC and B-cell non-Hodgkin lymphoma: Studies using inducible gene deletion revealed that a broad range of cancer cells, including AML [167], MYC driven B cell lymphomas [135], T cell lymphomas and lung cancer caused by loss of TP53 or mutations in Notch [168–170] require MCL-1 for sustained survival and growth.